Language
English
Publication Date
9-14-2023
Journal
Molecular Therapy Methods & Clinical Development
DOI
37674904
PMID
PMC10477751
PMCID
PMC10477751
PubMedCentral® Posted Date
8-18-2023
PubMedCentral® Full Text Version
Post-print
Abstract
Recombinant adeno-associated viruses (rAAVs) have emerged as one of the most promising gene therapy vectors that have been successfully used in pre-clinical models of heart disease. However, this has not translated well to humans due to species differences in rAAV transduction efficiency. As a result, the search for human cardiotropic capsids is a major contemporary challenge. We used a capsid-shuffled rAAV library to perform directed evolution in human iPSC-derived cardiomyocytes (hiPSC-CMs). Five candidates emerged, with four presenting high sequence identity to AAV6, while a fifth divergent variant was related to AAV3b. Functional analysis of the variants was performed
Keywords
adeno-associated virus, cardiotropic, hiPSC-CM, cardiac organoids, cardiac slices
Published Open-Access
yes
Recommended Citation
Kok, Cindy Y; Tsurusaki, Shinya; Cabanes-Creus, Marti; et al., "Development of New Adeno-Associated Virus Capsid Variants for Targeted Gene Delivery to Human Cardiomyocytes" (2023). Faculty, Staff and Students Publications. 8622.
https://digitalcommons.library.tmc.edu/baylor_docs/8622